Cargando…
ACE-inhibitors, Beta-blockers or the Combination in Heart Failure: Is It Just an A–B–C ?: EDITORIAL to: Effects of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure by Rosenberg et al.
Autores principales: | de Boer, Rudolf A., van Veldhuisen, Dirk J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2493529/ https://www.ncbi.nlm.nih.gov/pubmed/18418705 http://dx.doi.org/10.1007/s10557-008-6107-x |
Ejemplares similares
-
Treatment of heart failure with ACE inhibitors and beta-blockers: What is next? Aldosterone receptor antagonists?
por: van der Horst, Iwan C. C., et al.
Publicado: (2007) -
Disease-modifying medications in heart failure: more than ACE inhibitors and beta blockers
por: Chao, Chia-Ter
Publicado: (2011) -
Beta‐blocker use and mortality among patients with systolic heart failure and pacemaker rhythm
por: Perry, Andrew S., et al.
Publicado: (2023) -
Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011) -
New advances in beta-blocker therapy in heart failure
por: Barrese, Vincenzo, et al.
Publicado: (2013)